Insmed Inc (INSM)
24.50
-0.30
(-1.19%)
USD |
NASDAQ |
Apr 19, 10:10
Insmed Cash from Operations (TTM): -536.25M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -536.25M |
| September 30, 2023 | -508.58M |
| June 30, 2023 | -462.07M |
| March 31, 2023 | -441.58M |
| December 31, 2022 | -400.44M |
| September 30, 2022 | -381.42M |
| June 30, 2022 | -367.04M |
| March 31, 2022 | -340.18M |
| December 31, 2021 | -363.30M |
| September 30, 2021 | -345.96M |
| June 30, 2021 | -329.18M |
| March 31, 2021 | -289.69M |
| December 31, 2020 | -219.35M |
| September 30, 2020 | -196.96M |
| June 30, 2020 | -190.66M |
| March 31, 2020 | -234.74M |
| December 31, 2019 | -250.65M |
| September 30, 2019 | -276.41M |
| June 30, 2019 | -289.53M |
| March 31, 2019 | -264.41M |
| December 31, 2018 | -257.98M |
| September 30, 2018 | -236.03M |
| June 30, 2018 | -208.78M |
| March 31, 2018 | -190.12M |
| December 31, 2017 | -159.62M |
| Date | Value |
|---|---|
| September 30, 2017 | -169.36M |
| June 30, 2017 | -162.10M |
| March 31, 2017 | -154.09M |
| December 31, 2016 | -146.71M |
| September 30, 2016 | -116.29M |
| June 30, 2016 | -109.34M |
| March 31, 2016 | -105.34M |
| December 31, 2015 | -100.70M |
| September 30, 2015 | -86.08M |
| June 30, 2015 | -82.96M |
| March 31, 2015 | -76.65M |
| December 31, 2014 | -64.42M |
| September 30, 2014 | -65.54M |
| June 30, 2014 | -60.92M |
| March 31, 2014 | -48.10M |
| December 31, 2013 | -46.66M |
| September 30, 2013 | -41.53M |
| June 30, 2013 | -34.44M |
| March 31, 2013 | -36.61M |
| December 31, 2012 | -31.01M |
| September 30, 2012 | -28.15M |
| June 30, 2012 | -26.97M |
| March 31, 2012 | -30.71M |
| December 31, 2011 | -30.20M |
| September 30, 2011 | -33.06M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-536.25M
Minimum
Dec 2023
-190.66M
Maximum
Jun 2020
-338.10M
Average
-340.18M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
| NeuroMetrix Inc | -6.085M |
| Intra-Cellular Therapies Inc | -124.20M |
| Rhythm Pharmaceuticals Inc | -136.16M |
| Amylyx Pharmaceuticals Inc | 11.92M |
| AN2 Therapeutics Inc | -53.29M |